Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3 …

SH Kennedy, RW Lam, RS McIntyre… - The Canadian …, 2016 - journals.sagepub.com
Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT)
conducted a revision of the 2009 guidelines by updating the evidence and …

Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis

T Kishi, T Ikuta, K Sakuma, M Okuya, M Hatano… - Molecular …, 2023 - nature.com
A systematic review and random-effects model network meta-analysis were conducted to
compare the efficacy, acceptability, tolerability, and safety of antidepressants to treat adults …

The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

GS Malhi, E Bell, D Bassett, P Boyce… - Australian & New …, 2021 - journals.sagepub.com
Objectives: To provide advice and guidance regarding the management of mood disorders,
derived from scientific evidence and supplemented by expert clinical consensus to formulate …

[HTML][HTML] The identification, assessment and management of difficult-to-treat depression: an international consensus statement

RH McAllister-Williams, C Arango, P Blier… - Journal of Affective …, 2020 - Elsevier
Background Many depressed patients are not able to achieve or sustain symptom remission
despite serial treatment trials–often termed “treatment resistant depression”. A broader …

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 5 …

AV Ravindran, LG Balneaves… - The Canadian …, 2016 - journals.sagepub.com
Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT)
conducted a revision of the 2009 guidelines by updating the evidence and …

Cognitive impairment in major depressive disorder

Z Pan, C Park, E Brietzke, H Zuckerman, C Rong… - CNS …, 2019 - cambridge.org
Cognitive dysfunction is a symptomatic domain identified across many mental disorders.
Cognitive deficits in individuals with major depressive disorder (MDD) contribute …

Machine learning in the prediction of depression treatment outcomes: a systematic review and meta-analysis

M Sajjadian, RW Lam, R Milev, S Rotzinger… - Psychological …, 2021 - cambridge.org
Background Multiple treatments are effective for major depressive disorder (MDD), but the
outcomes of each treatment vary broadly among individuals. Accurate prediction of …

A framework for the empirical investigation of mindfulness meditative development

J Galante, A Grabovac, M Wright, DM Ingram… - Mindfulness, 2023 - Springer
Millions of people globally have learned mindfulness meditation with the goal of improving
health and well-being outcomes in both clinical and non-clinical contexts. An estimated half …

Treatment‐resistant major depressive disorder: Canadian expert consensus on definition and assessment

YE Rybak, KSP Lai, R Ramasubbu… - Depression and …, 2021 - Wiley Online Library
Background Treatment‐resistant depression (TRD) is a debilitating chronic mental illness
that confers increased morbidity and mortality, decreases the quality of life, impairs …

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force report: serotonergic psychedelic treatments for major depressive disorder

JD Rosenblat, MI Husain, Y Lee… - The Canadian …, 2023 - journals.sagepub.com
Objective Serotonergic psychedelics are re-emerging as potential novel treatments for
several psychiatric disorders including major depressive disorder. The Canadian Network …